07:00 , Oct 29, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Phospholipase A2 group IID (PLA2G2D)

Infectious disease INDICATION: Respiratory infection; viral infection; SARS-associated coronavirus In vitro and mouse studies suggest inhibiting PLA2G2D in the lungs could help treat viral respiratory infections in elderly patients. Lung levels of the pro-resolving, anti-inflammatory...